Eli Lilly and Co
XHAM:LLY

Watchlist Manager
Eli Lilly and Co Logo
Eli Lilly and Co
XHAM:LLY
Watchlist
Price: 926.9 EUR -1.45% Market Closed
Market Cap: 886.7B EUR

Relative Value

The Relative Value of one LLY stock under the Base Case scenario is hidden EUR. Compared to the current market price of 926.9 EUR, Eli Lilly and Co is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

LLY Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
20
vs Industry
9
Median 3Y
16.2
Median 5Y
13.6
Industry
2.7
Forward
15.6
vs History
44
vs Industry
5
Median 3Y
69.1
Median 5Y
54.5
Industry
21.6
Forward
44.3
vs History
41
vs Industry
5
Median 3Y
81.4
Median 5Y
55.8
Industry
16.9
vs History
53
vs Industry
5
Median 3Y
84.2
Median 5Y
62.8
Industry
22.9
vs History
34
vs Industry
0
Median 3Y
46.5
Median 5Y
36.6
Industry
2.3
vs History
20
vs Industry
8
Median 3Y
16.8
Median 5Y
14.1
Industry
3
Forward
16.1
vs History
23
vs Industry
9
Median 3Y
20.9
Median 5Y
17.1
Industry
5.6
vs History
38
vs Industry
7
Median 3Y
47.2
Median 5Y
34
Industry
13.4
Forward
36.1
vs History
44
vs Industry
8
Median 3Y
54.1
Median 5Y
39.7
Industry
16.7
Forward
38.7
vs History
42
vs Industry
5
Median 3Y
84.1
Median 5Y
58
Industry
16.1
vs History
6
vs Industry
0
Median 3Y
-190.3
Median 5Y
48.5
Industry
18.9
vs History
25
vs Industry
8
Median 3Y
10.1
Median 5Y
8.2
Industry
2

Multiples Across Competitors

LLY Competitors Multiples
Eli Lilly and Co Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Eli Lilly and Co
XHAM:LLY
1T EUR 16.9 54.6 36.7 39.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
491.8B USD 5.3 19.6 16 20.8
CH
Roche Holding AG
SIX:ROG
271.4B CHF 4.4 28.8 12.2 14.3
UK
AstraZeneca PLC
LSE:AZN
220.4B GBP 5.1 31.4 108.8 159.2
US
Merck & Co Inc
NYSE:MRK
274.9B USD 4.3 14.4 10.2 12.1
CH
Novartis AG
SIX:NOVN
218.8B CHF 4.9 19 12 15.5
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK 5.4 16.3 11.3 13.2
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
144.9B USD 2.3 14.7 7.5 10.2
FR
Sanofi SA
PAR:SAN
102.8B EUR 1.5 7.4 6.8 6.8
P/E Multiple
Earnings Growth PEG
US
Eli Lilly and Co
XHAM:LLY
Average P/E: 22.9
54.6
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.6
29%
0.7
CH
Roche Holding AG
SIX:ROG
28.8
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.4
37%
0.8
US
Merck & Co Inc
NYSE:MRK
14.4
15%
1
CH
Novartis AG
SIX:NOVN
19
17%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
16.3
3%
5.4
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.7
27%
0.5
FR
Sanofi SA
PAR:SAN
7.4
26%
0.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Eli Lilly and Co
XHAM:LLY
Average EV/EBITDA: 400.6
36.7
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16
9%
1.8
CH
Roche Holding AG
SIX:ROG
12.2
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.8
10%
10.9
US
Merck & Co Inc
NYSE:MRK
10.2
6%
1.7
CH
Novartis AG
SIX:NOVN
12
6%
2
DK
Novo Nordisk A/S
CSE:NOVO B
11.3
1%
11.3
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
FR
Sanofi SA
PAR:SAN
6.8
8%
0.8
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Eli Lilly and Co
XHAM:LLY
Average EV/EBIT: 1 713
39.3
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
20.8
15%
1.4
CH
Roche Holding AG
SIX:ROG
14.3
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
159.2
23%
6.9
US
Merck & Co Inc
NYSE:MRK
12.1
8%
1.5
CH
Novartis AG
SIX:NOVN
15.5
12%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
13.2
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5
FR
Sanofi SA
PAR:SAN
6.8
15%
0.5